February 3, 2023 Journal Club Axicabtagene Ciloleucel as a Second-Line Therapy for Large B-Cell Lymphoma Dr. Jon Day, PGY-3 Mentor: Dr. Brian Link Article: Axicabtagene ciloleucel as a second-line therapy for large B cell lymphoma